References
- Kaneko J, Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004;68:981–1003.
- Prévost G, Cribier B, Couppié P, et al Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun. 1995;3:4121–4129.
- Gravet A, Colin DA, Keller D, et al Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 1998;436:202–208.
- Morinaga N, Kaihou Y, Noda M. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol. 2003;47:81–90.
- Olson R, Nariya H, Yokota K, et al Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat Struct Biol. 1999;6:134–140.
- Yokota K, Kamio Y. Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes. Biosci Biotechnol Biochem. 2000;64:2744–2747.
- Monma N, Nguyen VT, Kaneko J, et al Essential residues, W177 and R198, of LukF for phosphatidylcholine-binding and pore-formation by staphylococcal gamma-hemolysin on human erythrocyte membranes. J Biochem. 2004;136:427–431.
- Peng Z, Takeshita M, Shibata N, et al. Rim domain loops of Staphylococcal β-pore forming bi-component toxin S-components recognize target human erythrocytes in a coordinated manner. J Biochem. 2018;164:93–102.
- Spaan AN, Reyes-Robles T, Badiou C, et al Staphylococcus aureus targets the Duffy Antigen Receptor for Chemokines (DARC) to lyse erythrocytes. Cell Host Microbe. 2015;18:363–370.
- Reyes-Robles T, Alonzo F 3rd, Kozhaya L, et al Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe. 2013;14:453–459.
- Spaan AN, Vrieling M, Wallet P, et al The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat Commun. 2014;5:5438.
- Alonzo F 3rd, Kozhaya L, Rawlings SA, et al CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature. 2013;493:51–55.
- Spaan AN, Van Strijp JAG, Torres VJ. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. Nat Rev Microbiol. 2017;15:435–447.
- Deng H, Liu R, Ellmeier W, et al Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661–666.
- Maeda K, Yoshimura K, Shibayama S, et al Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5. J Biol Chem. 2001;276:35194–35200.
- Tam K, Schultz M, Reyes-Robles T, et al Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 target different sequence determinants on CCR5. MBio. 2016;7:pii:e02024–16.